302 related articles for article (PubMed ID: 16569343)
1. Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.
Di Lorenzo G; De Placido S
Int J Immunopathol Pharmacol; 2006; 19(1):11-34. PubMed ID: 16569343
[TBL] [Abstract][Full Text] [Related]
2. Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.
Prezioso D; Galasso R; Di Martino M; Iapicca G; Annunziata E; Iacono F
Anticancer Res; 2007; 27(2):1095-104. PubMed ID: 17465249
[TBL] [Abstract][Full Text] [Related]
3. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.
Sava T; Basso U; Porcaro A; Cetto GL
Expert Rev Anticancer Ther; 2005 Feb; 5(1):53-62. PubMed ID: 15757438
[TBL] [Abstract][Full Text] [Related]
4. Second-line chemotherapy for advanced hormone-refractory prostate cancer.
Garmey EG; Sartor O; Halabi S; Vogelzang NJ
Clin Adv Hematol Oncol; 2008 Feb; 6(2):118-22, 127-32. PubMed ID: 18347563
[TBL] [Abstract][Full Text] [Related]
5. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
Berry W; Eisenberger M
Oncologist; 2005; 10 Suppl 3():30-9. PubMed ID: 16368869
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hormone refractory prostate cancer.
Knox JJ; Moore MJ
Semin Urol Oncol; 2001 Aug; 19(3):202-11. PubMed ID: 11561988
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
Oh WK; Tay MH; Huang J
Cancer; 2007 Feb; 109(3):477-86. PubMed ID: 17186531
[TBL] [Abstract][Full Text] [Related]
8. Management of the spectrum of hormone refractory prostate cancer.
Clarke NW
Eur Urol; 2006 Sep; 50(3):428-38; discussion 438-9. PubMed ID: 16797118
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options in androgen-independent prostate cancer: building on docetaxel.
Petrylak D
BJU Int; 2005 Dec; 96 Suppl 2():41-6. PubMed ID: 16359438
[TBL] [Abstract][Full Text] [Related]
10. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapeutic approaches for hormone-refractory prostate cancer.
Stavridi F; Karapanagiotou EM; Syrigos KN
Cancer Treat Rev; 2010 Apr; 36(2):122-30. PubMed ID: 20106600
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in advanced prostate cancer.
Beedassy A; Cardi G
Semin Oncol; 1999 Aug; 26(4):428-38. PubMed ID: 10482185
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approach to hormone-refractory prostate cancer.
Saad F; Al Dejmah A; Perrotte P; McCormack M; Bénard F; Valiquette L; Karakiewicz PI
Can J Urol; 2006 Apr; 13 Suppl 2():52-6. PubMed ID: 16672130
[TBL] [Abstract][Full Text] [Related]
14. The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer.
Berry WR
Urology; 2005 Jun; 65(6 Suppl):2-7. PubMed ID: 15939076
[TBL] [Abstract][Full Text] [Related]
15. The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer.
Petrioli R; Fiaschi AI; Francini E; Pascucci A; Francini G
Cancer Treat Rev; 2008 Dec; 34(8):710-8. PubMed ID: 18620815
[TBL] [Abstract][Full Text] [Related]
16. New drugs in prostate cancer.
Armstrong AJ; Carducci MA
Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
[TBL] [Abstract][Full Text] [Related]
17. The role of chemotherapy in prostate cancer. Minireview.
Odrázka K; Vanásek J; Vaculíková M; Stejskal J; Filip S
Neoplasma; 2000; 47(4):197-203. PubMed ID: 11043822
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for non-hormone refractory prostate cancer.
Winquist E
Can J Urol; 2006 Feb; 13 Suppl 1():67-70. PubMed ID: 16526986
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for hormone-refractory prostate cancer: now it's a question of "when?".
Ryan CJ; Eisenberger M
J Clin Oncol; 2005 Nov; 23(32):8242-6. PubMed ID: 16278479
[TBL] [Abstract][Full Text] [Related]
20. Doxetaxel: new indication. Prostate cancer: a few more weeks.
Prescrire Int; 2006 Feb; 15(81):6-7. PubMed ID: 16548096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]